<DOC>
	<DOCNO>NCT02221661</DOCNO>
	<brief_summary>The purpose study assess performance AclarusDx™ , investigational blood test detect gene expression information , intend help physician make Alzheimer 's Disease diagnosis patient memory complaint and/or cognitive impairment .</brief_summary>
	<brief_title>Performance AclarusDx® Blood-Based Transcriptomic Test AD , French Patients Newly Referred Memory Center</brief_title>
	<detailed_description>The objective study apply AclarusDx™ signature 600 patient newly refer french memory center . Only AclarusDx™ add panel test usually perform center establish diagnosis . AclarusDx™ use investigational use , diagnostic purpose . The ultimate goal define clinical utility AclarusDx™ provide physician tool help making diagnosis Alzheimer 's Disease ( AD ) . The primary objective estimate prevalence positive AclarusDx™ patient diagnose AD population primary consultant . This population primary consultant consist patient cognitive impairment / memory complaint require specialize exploration use AclarusDx™ blood test may potentially related multiple different etiology . The secondary objective : - Assess prevalence positive AclarusDx™ relation diagnosis ( MCI , vascular dementia ... ) establish physician investigator end specialize assessment . - Identify demographic factor anamnestic , clinical , biological imaging associate positivity AclarusDx™ - Identify demographic factor anamnestic , clinical , biological imaging associate diagnosis AD diagnose . - Determine contribution AclarusDx™ usual battery test perform diagnostic approach Alzheimer 's disease identify possible association interest one endpoint ( clinical , neuropsychological , brain , biological imaging ) . - Assess : diagnostic status 6 12 month , MMSE IADL 6 12 month . - ass predictive value AclarusDx™ achieve initial visit diagnosis AD 12 month . - Evaluate AclarusDx™ predictive value 12 month</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>male female adult patient suffer cognitive impairment and/or memory complaint justify first clinical investigation memory center patient already follow memory center patient unable comply study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Alzheimer</keyword>
	<keyword>cognitive impairment</keyword>
	<keyword>blood test</keyword>
</DOC>